CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Visiospatial InterferenceWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D014947 Wounds and Injuries NIH 0.22

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Using a Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women

This research study is an extension on a study already preregistered NCT04209283 and is designed to investigate the use of a simple cognitive task (a memory cue followed by playing the computer game "Tetris") for decreasing the number of intrusive memories of trauma among trauma-exposed women in Iceland. This is a single case series using a within subject multiple baseline AB design. Participants will aim to complete a no-intervention phase ('A': baseline phase) of one week followed by a one-week intervention phase ('B'), including a one-session intervention with a researcher comprising the simple cognitive task, followed by instructions to continue using the technique self-guided in subsequent weeks. Participants will be asked to monitor the occurrence of intrusive memories of trauma in a daily diary. It is predicted that participants will report fewer intrusive memories during the intervention phase than during the preceding baseline phase and that the frequency of targeted intrusive memories is going to decrease relative to non-targeted intrusive memories. Furthermore, the investigators will explore whether having fewer intrusive memories has an impact on function and/or PTSD, depressive or anxiety symptoms.

NCT04342416 Trauma Behavioral: Visiospatial Interference
MeSH:Wounds and Injuries

Primary Outcomes

Description: Number of intrusive memories of traumatic event recorded by participants in a diary daily (morning, afternoon, evening and night) for one week during the baseline phase and each week during the intervention phase (week 1-6) and during one week at one month follow-up and three month follow-up.

Measure: Change in the number of intrusive memories of trauma

Time: Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up

Secondary Outcomes

Description: How often did you manage to play Tetris after you experienced an intrusive memory? (11-point scale; 0 = not at all; 10 = every time).

Measure: Self-guided intervention adherence - usage of the gameplay intervention in daily life

Time: Intervention week 2-6

Description: Feasibility and Acceptability of the intervention assessed with two self-rated items, "Would you recommend playing Tetris to a friend?" and "Do you consider gameplay to be an acceptable way to reduce the daily frequency of intrusive memories?". Scores could range from 0 - 10 with higher scores indicating greater acceptability/feasibility.

Measure: Feasibility and acceptability ratings for using a smartphone game-play intervention

Time: Post intervention up to week 7

Description: Two open-ended questions: 1. "How did you feel about playing Tetris after you had an intrusive memory?" 2. "Did you find the intervention helpful? If yes, how?"

Measure: Feasibility and acceptability - open ended questions

Time: Post intervention up to week 7

Description: Six self-rated items to assess the impact of intrusive memories on concentration, sleep, and stress in the past week. 2 items assessing concentration difficulties in general and due to intrusive memories (11-point scale; high scores indicating more difficulties). 2 items assessing sleep disturbances due to intrusive memories (11-point scale; higher scores indicating more sleep disturbance); and 1 item assessing to what degree intrusive memories affected stress levels (0 = not at all; 10 = affected very much).

Measure: Impact of intrusive memories on concentration, sleep and stress - ratings

Time: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up

Description: 1 item assessing for how long intrusive memories disrupted concentration on average on a 6-point scale (0 = <1 minute - 6 = > 60 minutes)

Measure: Rating of how long intrusive memories disrupted concentration on average

Time: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up

Description: Two items both rated on an 11-point scale: 1. "During the last week, how distressing were your intrusive memories (0 = not at all; 10 = very distressing). 2. During the last week, how vivid were your intrusive memories (0 = not at all; 10= very vivid)

Measure: General impact of intrusive memories - ratings

Time: Baseline week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up

Description: Adherence to the intrusion diary assessed with 1 item: "How accurately did you fill out the diary?" (0= not at all; 10 = very accurately)

Measure: Intrusion diary adherence

Time: Baseline phase week 1; Intervention week 1-6; 1 month follow-up and 3 month follow-up

Description: The PCL-5 is a short 20-item self-report scale used to assess the severity of PTSD symptoms corresponding to the DSM-5 criteria for PTSD. Symptoms are rated from 0-4. Higher scores indicate greater severity.

Measure: The Posttraumatic Stress Disorder Checklist 5 (PCL-5)

Time: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up

Description: The PHQ-9 is a 9-item self-report measure of depression symptoms and the severity of those symptoms. Each item can be scored from 0 (i.e., not at all) to 3 (i.e., nearly every day).

Measure: The Patient Health Questionnaire-9 (PHQ-9)

Time: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up

Description: The GAD-7 is a brief self-report questionnaire designed as a screening tool for symptoms of general anxiety disorder and their severity. Each item can be scored from 0 (i.e., not at all) to 3 (i.e., nearly every day).

Measure: The Generalized Anxiety Disorder-7 scale (GAD-7)

Time: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up

Description: The SDS is a self-report questionnaire which is designed to assess functional impairment across three domains: (1) Work/school, (2) social, and (3) family life. These domains are measured on an 11-point scale which ranges from 0 (i.e., not at all) to 10 (i.e., extremely). The scale will be adjusted to assess impairment associated with intrusive memories.

Measure: The Sheehan Disability Scale (SDS)

Time: Baseline week 1; Post intervention up to week 7; 1 month follow-up and 3 month follow-up

Description: Two questions assessing the impact intrusive memories have on functioning in daily life. One question is open-ended: "Have the intrusive memories affected your ability to function in your daily life in the past week? If yes, how?" and one question is self-rated: "Have the intrusive memories affected your ability to function in your daily life?" (11-point scale, higher score indicate greater impact on functioning.)

Measure: Impact of intrusive memories on functioning

Time: Baseline week 1; Post intervention up to week 7, 1 month follow-up and 3 month follow-up


No related HPO nodes (Using clinical trials)